Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 688
Selected: 0
NCT IDTitle
NCT03697603A Study of Brexpiprazole in Patients With Major Depressive Disorder
NCT02573350A Trial to Evaluate Safety, Tolerability, and Efficacy of Orally Administered OPC-67683
NCT00520650Health Evaluation of Abilify Long-term Therapy
NCT01228682Post-Authorisation Safety Study of Samsca (Tolvaptan) Used in Routine Medical Practice
NCT02098460To Compare the Effect of Concomitant Administration of Probucol and Cilostazol With Probucol Single Treatment on the Atherosclerosis Related Markers (Including the Thickness of the Achilles Tendon) and Evaluate Safety (Based on Atorvastatin Treatment) in Severe Hypercholesterolemia Subject
NCT03303079Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Chronic Migraine
NCT05504486Open-label Brexpiprazole fMRI Trial in Adults With Major Depressive Disorder and Anxiety
NCT03620981Brexpiprazole for the Treatment of Patients With Agitation Associated With Dementia of the Alzheimer's Type
NCT03406286Samsca PMS in ADPKD Patients
NCT06971731A Study of JNT-517 in Participants With Phenylketonuria (PKU)
NCT02069119A Trial to Determine the Safety, Pharmacokinetics, and Efficacy of OPC-108459 Administered as a Single Intravenous Dose to Patients With Paroxysmal or Persistent Atrial Fibrillation (AF)
NCT04186403Evaluating the Safety and Tolerability of Brexpiprazole in the Treatment of Adults With Borderline Personality Disorder (BPD)
NCT02054702Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Acute Schizophrenia
NCT03179787Post-Marketing Surveillance Study of Aripiprazole in Patients With Autism
NCT03342963Bioequivalence Between Single Administration of ASC-01 (Aripiprazole/Sertraline Combination Drug) and Concomitant Single Administration of Aripiprazole and Sertraline, and Food Effect on Pharmacokinetics of ASC-01 in Healthy Male Adults
NCT03911401Comparison Trial of OPA-15406 Ointment in Pediatric Patients With Atopic Dermatitis
NCT00002130A Long-Term, Follow-On Safety Study of Four Doses of OPC-8212 (Vesnarinone) in HIV-Infected Persons
NCT03661983Trial to Evaluate the Long-term Efficacy of Oral Aripiprazole in the Treatment of Pediatric Participants With Tourette's Disorder
NCT03568383Protecting Households On Exposure to Newly Diagnosed Index Multidrug-Resistant Tuberculosis Patients
NCT00545142Abilify in Bipolar Disorder for 6 Weeks Treatment Effectiveness
NCT00239356Aripiprazole for Schizophrenia Outpatients Completing BMS Clinical Trials
NCT00428948Tolvaptan Phase 3 Efficacy and Safety Study in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
NCT00300846A Study of Adjunctive Treatment of Aripiprazole in Schizophrenic Patients
NCT00064441FACTS I: A Study to Test the Safety and Effectiveness of a New Medication on the Treatment of Active Ulcerative Colitis
NCT01838681Brexpiprazole as Adjunctive Treatment in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment
NCT02251275Long Term Safety of Immediate-release Tolvaptan in Subjects With Autosomal Dominant Polycystic Kidney Disease
NCT02994394A Study of OPC-41061 Orally Disintegrating (OD) Tablets Using 2 Different Formulations and 2 Dosing Regimens in Healthy Adult Male Subjects
NCT06799520A Phase 1 Trial to Evaluate the Safety, Tolerability, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of VIS171 in Participants With Autoimmune Disease(s)
NCT03018691Phase 2 Study of OPA-15406 Ointment in Pediatric Patients With Atopic Dermatitis
NCT01677338Phase 2 Study to Evaluate the Preliminary Performance of the C13-URA Breath Test Kit in Dyspeptic Subjects
NCT01360632Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)
NCT01628965A Long-Term Extension Trial From Phase II/III of SPM 962 in Early Parkinson's Disease Patients
NCT00791999Efficacy Confirmation Trial of CDP870 as add-on Medication to Methotrexate (MTX) in Japanese Rheumatoid Arthritis (RA)
NCT01052077Study of the Safety and Efficacy of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder
NCT00508157A Phase 4 Study to Assess the Effects of Aripiprazole Versus Other Atypical Antipsychotics in the Treatment of Schizophrenic Patients With Metabolic Syndrome
NCT01406574Phase I/II Study of OPB-31121 in Patients With Progressive Hepatocellular Carcinoma
NCT03254108Clinical Pharmacology Trial to Investigate the Dose of OPC-61815 Injection Equivalent to Tolvaptan 15-mg Tablet in Patients With Congestive Heart Failure
NCT02442674A Trial of Tolvaptan in Children and Adolescent Subjects With Euvolemic and Hypervolemic Hyponatremia
NCT03292848Trial to Assess the Pharmacokinetics, Safety, Tolerability of Oral Brexpiprazole in Children (6 to <13 Years Old) With Central Nervous System Disorders
NCT07166796a Phase I PK Study in Healthy Male Subjects. 2 Groups of Healthy Male Subjects
NCT05536414Trial of Centanafadine Efficacy and Safety as Monotherapy or as Adjunct to SSRI in Adults With Major Depressive Disorder
NCT01199198Tolvaptan in Hyponatremic Cancer Patients
NCT02293993Phase 1 Study of SGI-110 in Patients With Acute Myeloid Leukemia
NCT00822172Evaluation of Cilostazol in Combination With L-Carnitine
NCT04719637Clinical Study of an Ultrasound Renal Denervation System in Patients With Heart Failure
NCT00332241Study of Aripiprazole in the Treatment of Children and Adolescents With Autistic Disorder (AD)
NCT00002129A Phase I Study of Three Doses of OPC-8212 (Vesnarinone) in HIV-Infected Persons With CD4+ Cell Number > 300 Cells/mm3
NCT07166783Single Dose of 7.5mg Tolvaptan Phase I Clinical Trial Protocol
NCT03303105Long-term Safety and Tolerability of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
NCT01959035Aripiprazole Once-monthly in Patients With Schizophrenia